Tupperware Brands Corporation (NYSE:TUP) reported Q3 earnings and revenue that fell short of Street expectations. Tupperware Brands Corporation (NYSE:TUP) reported GAAP diluted E.P.S. $0.63 versus $0.95 prior year and adjusted, diluted E.P.S. of $0.90, up 5% in local currency. The Street expected $0.91 per share, according to Capital IQ estimates. Net sales were $588.7 million, versus the $589.5 million the Street expected. For Q4 2014, Tupperware expects GAAP earnings of $1.45 to $1.50 and non-GAAP earnings of $1.55 to $1.60 with a sales decline of 6% to 4%. Analysts call for $1.70 in earnings and $698 million in revenue for Q4. For Fiscal 2014, it expects GAAP earnings of between $4.02 to $4.07 and non-GAAP earnings of $5.21 to $5.26 with a sales decline of 3% to 2%. That's off from the Street view of $5.39. TUP trades in a 52-week range of $66.86 to $97.14, with shares having closed up 2.5% in Tuesday's session.The Medicines Company (NASDAQ:MDCO) reported that for Q3 ended Sept. 30, 2014, it missed analysts' expectations for both its top and bottom lines. The pharmaceutical company posted Q3 net loss of $16.7 million, or $0.26 loss per share, compared with the prior-year period's net income of $7.8 million, or $0.12 per share. Adjusted net income was $11.6 million, or $0.18 per share, versus $29.3 million, or $0.47 per share in the same quarter the previous year. Revenue was $172.4 million, down from $174.3 million in the same quarter last year. Analysts polled by Capital IQ were expecting EPS of $0.37 on revenues of $188.39 million. The Medicines Company (NASDAQ:MDCO) shares closed at $23.34 with a 52-week range of $19.92 - $41.28.The Dow Chemical Company (NYSE:DOW) reported Q3 earnings above analysts' expectations on revenue that also topped the Street view. DOW trades in a 52-week range of $38.16 to $54.97. Net income available to the company's common stockholders climbed to $852 million, or $0.71 per diluted share, from $594 million, or $0.49 per diluted share, a year earlier. On an adjusted basis, The Dow Chemical Company (NYSE:DOW) earned $0.72 per share in the latest quarter, up from $0.50 per share a year earlier. Analysts polled by Capital IQ were expecting $0.67 per share.Net sales rose to $14.41 billion from $13.73 billion a year earlier, topping analysts' mean estimate of $14.30 billion. The company said the sales increase was "driven by price increases associated with tightening demand conditions in key regions, with gains in most operating segments." Sales also increased in all geographic areas. Leading the sales gains, its performance plastics segment posted a 9% adjusted sales increase while performance materials sales climbed 8% on an adjusted basis. "We remain committed to achieving our financial targets and ongoing shareholder remuneration, and are taking targeted steps across our businesses to navigate through persistently slow and volatile global macroeconomic conditions," said Chairman and CEO Andrew N. Liveris.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
